Genomma Lab sets third-quarter date and Genomma Lab stock gains 3.17 percent

Published on 10/07/2026 at 14:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue reached MXN 4,397.04 million, up 4.93 percent quarter over quarter. Genomma Lab stock costs EUR 0.65 on October 7, 2026 after EUR 0.63.

Genomma Lab, MX01LA010006, Illustration mit AI erstellt.

Genomma Lab (MX01LA010006) stock was trading at EUR 0.65 at Lang & Schwarz on October 7, 2026 at 2:19 p.m. CEST, up 3.17 percent versus the prior close of EUR 0.63. According to Morningstar on October 1, 2026, the company will report its third-quarter results on October 21, 2026, after the Mexican Stock Exchange close. Genomma Lab stock gains 3.17 percent in the euro quote, giving the scheduled report a market backdrop that is materially stronger than the prior close.

October results date is set

The October 21 release is followed by a conference call on October 22, 2026, at 11:00 a.m. Mexico City time, according to Morningstar. The release identifies Genomma Lab as a pharmaceutical and personal care products company listed on the BMV under LAB B, with products sold in Mexico and international markets.

Second-quarter revenue edges higher

For the second quarter of 2026, revenue was MXN 4,397.04 million, compared with MXN 4,190.62 million in the previous quarter, an increase of 4.93 percent, according to Investing.com. Net income was MXN 374.49 million, while the previous quarter showed MXN 494.65 million, a decline of 24.30 percent. The contrast matters: sales improved sequentially, but earnings conversion weakened before the third-quarter update.

The same second-quarter summary puts earnings per share at MXN 0.37 against a MXN 0.54 forecast. That 31.48 percent shortfall leaves the October report with two measurable questions: whether revenue growth continued and whether profitability recovered.

BMV quote remains below yearly high

The BMV quote stood at MXN 12.91 on October 7, 2026 at 10:17 a.m. CST, while the 52-week range was MXN 12.22 to MXN 19.48. The market capitalization was MXN 12.6 billion on the same date, according to the quoted market data. The current BMV price is 33.73 percent below the 52-week high, keeping the upcoming results relevant for valuation as well as operating performance.

Euro quote rises above prior close

At Lang & Schwarz, Genomma Lab stock was trading at EUR 0.65 on October 7, 2026 at 2:19 p.m. CEST, plus 3.17 percent versus the Lang & Schwarz prior close of EUR 0.63 on October 6, 2026. The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.